On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis (vol 38, pg 2225, 2018)

被引:0
作者
Bykerk, Vivian P. [1 ]
Burmester, Gerd R. [2 ]
Combe, Bernard G. [3 ]
Furst, Daniel E. [4 ]
Huizinga, Tom W. J. [5 ]
Ahmad, Harris A. [6 ]
Emery, Paul [7 ,8 ]
机构
[1] Weill Cornell Med Coll, Hosp Special Surg, Dept Rheumatol, 535 East 70th St, New York, NY 10021 USA
[2] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany
[3] Dept Rheumatol, Serv Immunorheumatol, Montpellier, France
[4] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
[5] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[6] Bristol Myers Squibb, Headquarters Med Immunol, Princeton, NJ USA
[7] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[8] Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
关键词
D O I
10.1007/s00296-018-4232-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The article “On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis”, written by Vivian P.Bykerk, was originally published Online First without open access.
引用
收藏
页码:945 / 945
页数:1
相关论文
共 1 条
[1]   On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis [J].
Bykerk, Vivian P. ;
Burmester, Gerd R. ;
Combe, Bernard G. ;
Furst, Daniel E. ;
Huizinga, Tom W. J. ;
Ahmad, Harris A. ;
Emery, Paul .
RHEUMATOLOGY INTERNATIONAL, 2018, 38 (12) :2225-2231